Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer von Zweifel, M., Jayson, G.C., Reed, N.S., Osborne, R., Hassan, B., Ledermann, J., Shreeves, G., Poupard, L., Lu, S.-P., Balkissoon, J., Chaplin, D.J., Rustin, G.J.S.

Volltext

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, p... von Glasspool, R M, Brown, R, Gore, M E, Rustin, G J S, McNeish, I A, Wilson, R H, Pledge, S, Paul, J, Mackean, M, Hall, G D, Gabra, H, Halford, S E R, Walker, J, Appleton, K, Ullah, R, Kaye, S

Volltext

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations von LEACH, Mo, BRINDLE, Km, MCINTYRE, D, PADHANI, Ar, PRICE, P, RATHBONE, R, RUSTIN, Gj, TOFTS, Ps, TOZER, Gm, VENNART, W, WATERTON, Jc, WILLIAMS, Sr, EVELHOCH, Jl, WORKMAN, P, GRIFFITHS, Jr, HORSMAN, Mr, JACKSON, A, JAYSON, Gc, JUDSON, Ir, KNOPP, Mv, MAXWELL, Rj

Volltext

Role of tumour markers in monitoring epithelial ovarian cancer von MEYER, T, RUSTIN, G. J. S

Volltext

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125 von RUSTIN, G. J. S, NELSTROP, A. E, MCCLEAN, P, BRADY, M. F, MCGUIRE, W. P, HOSKINS, W. J, MITCHELL, H, LAMBERT, H. E

Volltext

EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients von BOWER, M, NEWLANDS, E. S, HOLDEN, L, SHORT, D, BROCK, C, RUSTIN, G. J. S, BEGENT, R. H. J, BAGSHAWE, K. D

Volltext

Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study von Rustin, G. J. S., Nelstrop, A. E., Tuxen, M. K., Lambert, H. E.

Volltext

Phase I trial of elactocin von NEWLANDS, E. S, RUSTIN, G. J. S, BRAMPTON, M. H

Volltext

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer? von Rustin, G.J.S., Hall, M.R.

Volltext

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer von Rustin, G J, Shreeves, G, Nathan, P D, Gaya, A, Ganesan, T S, Wang, D, Boxall, J, Poupard, L, Chaplin, D J, Stratford, M R L, Balkissoon, J, Zweifel, M

Volltext

Vascular Damaging Agents von Patterson, D.M, Rustin, G.J.S

Volltext

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors von RUSTIN, G. J. S, NEWLANDS, E. S, LUTZ, J.-M, HOLDEN, L, BAGSHAWE, K. D, HISCOX, J. G, FOSKETT, M, FULLER, S, SHORT, D

Volltext

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856) von NEWLANDS, E. S, BLACKLEDGE, G. R. P, GIBSON, A. C, SLACK, J. A, RUSTIN, G. J. S, SMITH, D. B, STUART, N. S. A, QUATERMAN, C. P, HOFFMAN, R, STEVENS, M. F. G, BRAMPTON, M. H

Volltext

Surveillance policy for stage I ovarian germ cell tumors von DARK, G. G, BOWER, M, NEWLANDS, E. S, PARADINAS, F, RUSTIN, G. J. S

Volltext

Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma von BLEEHEN, N. M, NEWLANDS, E. S, LEE, S. M, THATCHER, N, SELBY, P, CALVERT, A. H, RUSTIN, G. J. S, BRAMPTON, M, STEVENS, M. F. G

Volltext

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours von FOSS, S. D, STENNING, S. P, MEAD, G. M, CULLEN, M. H, KAYE, S. B, RUSTIN, G. J. S, COOK, P. A, GERL, A, HORWICH, A, CLARK, P. I, WILKINSON, P. M, JONES, W. G, WILLIAMS, M. V, OLIVER, R. T, NEWLANDS, E. S

Volltext

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial von Ledermann, J.A., Embleton-Thirsk, A.C., Perren, T.J., Jayson, G.C., Rustin, G.J.S., Kaye, S.B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A.M., Kaplan, R.S., Parmar, M.K.B.

Volltext

Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000 von MCNEISH, I. A, STRICKLAND, S, HOLDEN, L, RUSTIN, G. J. S, FOSKETT, M, SECKL, M. J, NEWLANDS, E. S

Volltext

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc... von MEAD, G. M, CULLEN, M. H, HUDDART, R, HARPER, P, RUSTIN, G. J. S, COOK, P. A, STENNING, S. P, MASON, M

Volltext

Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy von Bower, M., Newlands, E. S., Holden, L., Rustin, G. J. S., Begent, R. H. J.

Volltext